FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387364737> ?p ?o ?g. }

• W4387364737 endingPage "e073797" @default.
• W4387364737 startingPage "e073797" @default.
• W4387364737 abstract "Introduction The feasibility and efficacy of surgical resection following systemic therapy for intermediate-stage hepatocellular carcinoma (HCC) beyond the Up-to-7 criteria is unclear. The combination of lenvatinib (LEN) and transcatheter arterial chemoembolisation (TACE), termed LEN–TACE sequential therapy, has shown a high response rate and survival benefit in patients with intermediate-stage HCC. This trial aims to evaluate the efficacy and safety of LEN–TACE sequential therapy and the feasibility of surgical resection for intermediate-stage HCC beyond the Up-to-7 criteria. Methods and analysis This is a multicentre, single-arm, prospective clinical trial. Thirty patients with intermediate-stage HCC beyond the Up-to-7 criteria will be enrolled. Patients eligible for this study will undergo LEN–TACE sequential therapy in which LEN is administered for 4 weeks, followed by TACE, and then further LEN for another 4 weeks. Patients will be assessed for efficacy of LEN–TACE sequential therapy and resectability, and surgical resection will be performed if the HCC is considered radically resectable. The primary outcome of this study is the resection rate after LEN–TACE sequential therapy. The secondary outcomes are the objective response rate of LEN–TACE sequential therapy, safety, curative resection rate, overall survival and recurrence-free survival. Ethics and dissemination This trial was approved by the Institutional Review Board of Hiroshima University, Japan (approval no. CRB210003), and has been registered with the Japan Registry of Clinical Trials (jRCTs061220007). The results of this study will be submitted for publication in a peer-reviewed journal and shared with the scientific community at international conferences. Trial registration number jRCTs061220007 ( https://jrct.niph.go.jp/latest-detail/jRCTs061220007 )." @default.
• W4387364737 created "2023-10-06" @default.
• W4387364737 creator A5008287349 @default.
• W4387364737 creator A5011235559 @default.
• W4387364737 creator A5017393726 @default.
• W4387364737 creator A5027196488 @default.
• W4387364737 creator A5031469873 @default.
• W4387364737 creator A5035029873 @default.
• W4387364737 creator A5038162545 @default.
• W4387364737 creator A5039957759 @default.
• W4387364737 creator A5040193709 @default.
• W4387364737 creator A5040817459 @default.
• W4387364737 creator A5047323917 @default.
• W4387364737 creator A5049886641 @default.
• W4387364737 creator A5052204317 @default.
• W4387364737 creator A5059550555 @default.
• W4387364737 creator A5061010308 @default.
• W4387364737 creator A5061436398 @default.
• W4387364737 creator A5069732243 @default.
• W4387364737 creator A5073707180 @default.
• W4387364737 date "2023-10-01" @default.
• W4387364737 modified "2023-10-13" @default.
• W4387364737 title "Efficacy and safety of lenvatinib–transcatheter arterial chemoembolisation sequential therapy followed by surgical resection for intermediate-stage hepatocellular carcinoma beyond Up-to-7 criteria: a study protocol for a multicentre, single-arm, prospective study" @default.
• W4387364737 cites W1755620415 @default.
• W4387364737 cites W1971837077 @default.
• W4387364737 cites W1995319315 @default.
• W4387364737 cites W1996703005 @default.
• W4387364737 cites W2075426209 @default.
• W4387364737 cites W2079586464 @default.
• W4387364737 cites W2080762633 @default.
• W4387364737 cites W2110643890 @default.
• W4387364737 cites W2118698732 @default.
• W4387364737 cites W2139248078 @default.
• W4387364737 cites W2186902482 @default.
• W4387364737 cites W2226763652 @default.
• W4387364737 cites W2277004004 @default.
• W4387364737 cites W2411583095 @default.
• W4387364737 cites W2461872804 @default.
• W4387364737 cites W2465327389 @default.
• W4387364737 cites W2787358630 @default.
• W4387364737 cites W2953756046 @default.
• W4387364737 cites W2974893314 @default.
• W4387364737 cites W2989005830 @default.
• W4387364737 cites W2995797322 @default.
• W4387364737 cites W2996066981 @default.
• W4387364737 cites W3042091422 @default.
• W4387364737 cites W3045887819 @default.
• W4387364737 cites W3094450571 @default.
• W4387364737 cites W3119233878 @default.
• W4387364737 cites W3136943868 @default.
• W4387364737 cites W3158785061 @default.
• W4387364737 cites W3159001445 @default.
• W4387364737 cites W3172110749 @default.
• W4387364737 cites W4210955410 @default.
• W4387364737 cites W4213096024 @default.
• W4387364737 doi "https://doi.org/10.1136/bmjopen-2023-073797" @default.
• W4387364737 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37798025" @default.
• W4387364737 hasPublicationYear "2023" @default.
• W4387364737 type Work @default.
• W4387364737 citedByCount "0" @default.
• W4387364737 crossrefType "journal-article" @default.
• W4387364737 hasAuthorship W4387364737A5008287349 @default.
• W4387364737 hasAuthorship W4387364737A5011235559 @default.
• W4387364737 hasAuthorship W4387364737A5017393726 @default.
• W4387364737 hasAuthorship W4387364737A5027196488 @default.
• W4387364737 hasAuthorship W4387364737A5031469873 @default.
• W4387364737 hasAuthorship W4387364737A5035029873 @default.
• W4387364737 hasAuthorship W4387364737A5038162545 @default.
• W4387364737 hasAuthorship W4387364737A5039957759 @default.
• W4387364737 hasAuthorship W4387364737A5040193709 @default.
• W4387364737 hasAuthorship W4387364737A5040817459 @default.
• W4387364737 hasAuthorship W4387364737A5047323917 @default.
• W4387364737 hasAuthorship W4387364737A5049886641 @default.
• W4387364737 hasAuthorship W4387364737A5052204317 @default.
• W4387364737 hasAuthorship W4387364737A5059550555 @default.
• W4387364737 hasAuthorship W4387364737A5061010308 @default.
• W4387364737 hasAuthorship W4387364737A5061436398 @default.
• W4387364737 hasAuthorship W4387364737A5069732243 @default.
• W4387364737 hasAuthorship W4387364737A5073707180 @default.
• W4387364737 hasBestOaLocation W43873647371 @default.
• W4387364737 hasConcept C126322002 @default.
• W4387364737 hasConcept C141071460 @default.
• W4387364737 hasConcept C143998085 @default.
• W4387364737 hasConcept C146357865 @default.
• W4387364737 hasConcept C151730666 @default.
• W4387364737 hasConcept C2776264508 @default.
• W4387364737 hasConcept C2776283816 @default.
• W4387364737 hasConcept C2778019345 @default.
• W4387364737 hasConcept C2778695046 @default.
• W4387364737 hasConcept C535046627 @default.
• W4387364737 hasConcept C71924100 @default.
• W4387364737 hasConcept C86803240 @default.
• W4387364737 hasConceptScore W4387364737C126322002 @default.
• W4387364737 hasConceptScore W4387364737C141071460 @default.
• W4387364737 hasConceptScore W4387364737C143998085 @default.
• W4387364737 hasConceptScore W4387364737C146357865 @default.
• W4387364737 hasConceptScore W4387364737C151730666 @default.
• W4387364737 hasConceptScore W4387364737C2776264508 @default.

• next